{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:12:59Z","timestamp":1760235179373,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus strain 2 (SARS-CoV-2) is a beta-coronavirus that emerged as a global threat and caused a pandemic following its first outbreak in Wuhan, China, in late 2019. SARS-CoV-2 causes COVID-19, a disease ranging from relatively mild to severe illness. Older people and those with many serious underlying medical conditions such as diabetes, heart or lung conditions are at higher risk for developing severe complications from COVID-19 illness. SARS-CoV-2 infections of adults can lead to neurological complications ranging from headaches, loss of taste and smell, to Guillain\u2013Barr\u00e9 syndrome, an autoimmune disease characterized by neurological deficits. Herein we attempt to describe the neurological manifestations of SARS-CoV2 infection with a special focus on Guillain-Barr\u00e9 syndrome.<\/jats:p>","DOI":"10.3390\/pathogens10080936","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T22:07:00Z","timestamp":1627250820000},"page":"936","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SARS-CoV-2 Infection and Guillain-Barr\u00e9 Syndrome"],"prefix":"10.3390","volume":"10","author":[{"given":"Huda","family":"Makhluf","sequence":"first","affiliation":[{"name":"Department of Mathematics and Natural Sciences, National University, La Jolla, CA 92037, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Madany","sequence":"additional","affiliation":[{"name":"Public Health, University of California, Irvine, CA 92697, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"SARS, MERS and COVID-19: Clinical manifestations and organ-system complications: A mini review","volume":"78","author":"Harb","year":"2020","journal-title":"Pathog. Dis."},{"key":"ref_2","first-page":"157","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_3","unstructured":"(2021, June 17). Johns Hopkins Coronavirus Resource Center. (n.d.). Available online: https:\/\/coronavirus.jhu.edu."},{"key":"ref_4","unstructured":"(2021, June 17). Centers for Disease Control and Prevention. (n.d.). Symptoms of COVID-19. Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurological Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jns.12382","article-title":"Guillain-Barr\u00e9 syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature","volume":"25","author":"Scheidl","year":"2020","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological Features of COVID-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000509581","article-title":"Mechanisms of Stroke in COVID-19","volume":"49","author":"Spence","year":"2020","journal-title":"Cerebrovasc. Dis."},{"key":"ref_10","first-page":"444","article-title":"Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection","volume":"12","author":"Harrington","year":"2021","journal-title":"Front Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eabc5801","DOI":"10.1126\/sciadv.abc5801","article-title":"Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia","volume":"6","author":"Brann","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wang, E.Y., Team, Y.I., Mao, T., Klein, J., Dai, Y., Huck, J.D., Jaycox, J.R., Liu, F., Zhou, T., and Israelow, B. (2021). Diverse Functional Autoantibodies in Patients with COVID-19. Nature, 1\u20136.","DOI":"10.1038\/s41586-021-03631-y"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/5974574","article-title":"The Immune Epitope Database: How Data Are Entered and Retrieved","volume":"2017","author":"Fleri","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: An observational multicentre study from two Italian hotspot regions","volume":"92","author":"Filosto","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.25987","article-title":"Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in COVID-19","volume":"89","author":"Fragiel","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: Causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","article-title":"Guillain-Barr\u00e9 Syndrome Associated with Zika Virus Infection in Colombia","volume":"375","author":"Parra","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: The early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain\u2013Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_23","unstructured":"Waldron, J., Krochmal, H., and Makhluf, H. (2017). Investigation of Cross-Reactive Epitopes between Zika Virus and Myelin Basic Protein, American Society for Microbiology."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: Molecular mimicry with human heat shock proteins as potential pathogenic mechanism","volume":"25","author":"Lucchese","year":"2020","journal-title":"Cell Stress Chaperones"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102556","DOI":"10.1016\/j.autrev.2020.102556","article-title":"Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons","volume":"19","author":"Lucchese","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health","volume":"1","author":"Elbe","year":"2017","journal-title":"Glob. Chall."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Singh, B., Lant, S., Cividini, S., Cattrall, J., Goodwin, L., Benjamin, L., Michael, B., Khawaja, A., de Moura Brasil Matos, A., and Alkeridy, W. (2021). Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: A systematic review and individual patient data meta-analysis. Lancet, Preprint.","DOI":"10.2139\/ssrn.3834310"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/jnnp-2020-324230","article-title":"Guillain-Barr\u00e9 syndrome in times of pandemics","volume":"91","author":"Leonhard","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/8\/936\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:34:22Z","timestamp":1760164462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/10\/8\/936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["pathogens10080936"],"URL":"https:\/\/doi.org\/10.3390\/pathogens10080936","relation":{},"ISSN":["2076-0817"],"issn-type":[{"type":"electronic","value":"2076-0817"}],"subject":[],"published":{"date-parts":[[2021,7,24]]}}}